Author

P. Mischel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. Agustinus· 1 shared B. Dameracharla· 1 shared B. Li· 1 shared B. Michael· 1 shared B. Ren· 1 shared B. Weigelt· 1 shared D. Landau· 1 shared E. Gratton· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Agustinus

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Oxidative Stress is a shared characteristic of ME/CFS and Long COVID

V. Shankar, J. Wilhelmy, B. Michael, L. Cervantes, V. Mallajosyula, R. Davis, M. Snyder, S. Younis, W. H. Robinson, S. Shankar, P. Mischel, H. Bonilla, M. Davis

This study identifies elevated oxidative stress in both ME/CFS and Long COVID patients through blood cell analysis, suggesting shared molecular mechanisms and potential therapeutic targets.

bioRxiv · May 4, 2024 · PreprintImmunology

Epigenetic dysregulation from chromosomal transit in micronuclei

A. Agustinus, R. Raviram, B. Dameracharla, J. Luebeck, S. Stransky, L. Scipioni, R. Myers, M. DiBona, M. Duran, B. Weigelt, S. Yomtoubian, E. Toufektchan, P. Mischel, V. Mittal, S. Shah, , S. F. Bakhoum

This study shows that chromosomal transit through micronuclei causes epigenetic dysregulation in cancer cells, leading to long-term chromatin accessibility abnormalities.

bioRxiv · Jan 12, 2022Cancer Biology

Discovery and Functional Characterization of Pro-growth Enhancers in Human Cancer Cells

P. Chen, P. Fiaux, B. Li, K. Zhang, N. Kubo, S. Jiang, R. Hu, S. Wu, M. Wang, W. Wang, G. P. McVicker, P. Mischel, B. Ren

The paper identifies and characterizes pro-growth enhancers in cancer cells using CRISPR screens, finding lineage-specific enhancers associated with poor prognosis and potential therapeutic targets.

bioRxiv · Feb 4, 2021 · PreprintCancer Biology